What is Evommune 's free cash flow?

Evommune (EVMN) reported free cash flow of -$2.75M in Q4 2025.

What does free cash flow mean?

Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.

Evommune EVMN Free cash flow

Discontinued — last reported Q4 '25

Free cash flow at other companies

PfizerPFE

$2.18B+23.0%

Bausch + LombBLCO

-$68M+49.6%

BillionToOne, Inc. BLLN

$10.96M+3,842%

Perrigo CompanyPRGO

-$127.4M-41.6%

Hims & Hers HealthHIMS

——

Other financials

Income statement

See full

Revenue$1.6M+3.5%

Gross profit$961.1K+10.9%

Operating income-$682.8K-2,027%

Net income-$7.0M-5,414%

EPS (diluted)-$0.36-1,700%

Balance sheet

See full

Cash & equivalents$1.1M+401%

Total debt$2.0M—

Total equity-$4.5M-3,048%

Total assets$7.2M—

Cash flow

See full

Operating cash flow-$424.6K-341%

CapEx$1.0-99.8%

Valuation

See full

Market cap$848.59M+39.5%

Enterprise value$849.52M—

P/S127.3×—

Profitability

See full

Gross margin53.7%—

Operating margin-30.7%—

Net margin-90.1%—

Returns & leverage

See full

Return on equity275.7%—

Debt / equity1.4×—

Current ratio1.2×—

Where this comes from

Calculated from Evommune ’s reported figures.

−$2.7Mnet cash from operating−$1.0capital expenditures=-$2.75M

The official record: Evommune ’s 10-K, filed March 27, 2026, on SEC EDGAR. View the filing →

Ask your AI about Evommune 's free cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Evommune 's free cash flow?: Evommune (EVMN) reported free cash flow of -$2.75M in Q4 2025.
What does free cash flow mean?: Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.